Skip to main content
PMC home page
Journal of Virology logoLink to Journal of Virology
. 1996 Oct;70(10):7335–7340. doi: 10.1128/jvi.70.10.7335-7340.1996

Definition of human immunodeficiency virus type 1 gp120 and gp41 cytotoxic T-lymphocyte epitopes and their restricting major histocompatibility complex class I alleles in simian-human immunodeficiency virus-infected rhesus monkeys.

G Voss 1, N L Letvin 1
PMCID: PMC190800  PMID: 8794394

Abstract

With the development of chimeric simian-human immunodeficiency virus (SHIV)-infected macaques as a model for assessing novel human immunodeficiency virus type I (HIV-1) envelope glycoprotein (Env)-based vaccine strategies for preventing HIV-1 infection in man, it will be important to determine HIV-1 Env-specific cytotoxic T-lymphocyte (CTL) responses in vaccinated and virus-infected monkeys. To facilitate performing such CTL studies, we have defined two HIV-1 Env CTL epitopes in SHIV-infected rhesus monkeys and characterized the major histocompatibility complex (MHC) class I alleles that bind these Env peptide fragments and present them to CTL. A 9-amino-acid (aa) fragment of HIV-1 gp4l (p6B, aa 553 to 561) is presented to CD8+ CTLs of SHIV-infected animals by the rhesus monkey HLA-B homolog molecule Mamu-B*12. An 8-aa HIV-1 gpl.20 peptide (p9CD, aa 117 to 124) represents a CTL epitope in rhesus monkeys restricted by the HLA-A homolog MHC allele Mamu-A*08. This gp120 CTL epitope is fully conserved in all simian immunodeficiency virus, HIV-1, and HIV-2 isolates that have been sequenced to date and exhibits functional cross-reactivity. Screening of 14 unselected rhesus monkeys for expression of the two novel MHC class I alleles revealed the presence of each of the alleles in more than 40% of the animals. The characterization of the two HIV-1 Env CTL epitopes and their restricting MHC class I alleles will provide a basis for studying vaccine- and virus-elicited cytotoxic effector cell responses in rhesus monkeys.

Full Text

The Full Text of this article is available as a PDF (271.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Autran B., Letvin N. L. HIV epitopes recognized by cytotoxic T-lymphocytes. AIDS. 1991;5 (Suppl 2):S145–S150. doi: 10.1097/00002030-199101001-00020. [DOI] [PubMed] [Google Scholar]
  2. Boyson J. E., Shufflebotham C., Cadavid L. F., Urvater J. A., Knapp L. A., Hughes A. L., Watkins D. I. The MHC class I genes of the rhesus monkey. Different evolutionary histories of MHC class I and II genes in primates. J Immunol. 1996 Jun 15;156(12):4656–4665. [PubMed] [Google Scholar]
  3. Burns D. P., Collignon C., Desrosiers R. C. Simian immunodeficiency virus mutants resistant to serum neutralization arise during persistent infection of rhesus monkeys. J Virol. 1993 Jul;67(7):4104–4113. doi: 10.1128/jvi.67.7.4104-4113.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Clerici M., Lucey D. R., Zajac R. A., Boswell R. N., Gebel H. M., Takahashi H., Berzofsky J. A., Shearer G. M. Detection of cytotoxic T lymphocytes specific for synthetic peptides of gp160 in HIV-seropositive individuals. J Immunol. 1991 Apr 1;146(7):2214–2219. [PubMed] [Google Scholar]
  5. Gotch F. M., Kelly C., Ellis S. A., Wallace L., Rickinson A. B., van der Poel J., Crumpton M. J., McMichael A. J. Characterization of the HLA-A2.2 subtype: T cell evidence for further heterogeneity. Immunogenetics. 1985;21(1):11–23. doi: 10.1007/BF00372237. [DOI] [PubMed] [Google Scholar]
  6. Gotch F., McAdam S. N., Allsopp C. E., Gallimore A., Elvin J., Kieny M. P., Hill A. V., McMichael A. J., Whittle H. C. Cytotoxic T cells in HIV2 seropositive Gambians. Identification of a virus-specific MHC-restricted peptide epitope. J Immunol. 1993 Sep 15;151(6):3361–3369. [PubMed] [Google Scholar]
  7. Gotch F., Nixon D., Gallimore A., McAdam S., McMichael A. Cytotoxic T lymphocyte epitopes shared between HIV-1, HIV-2, and SIV. J Med Primatol. 1993 Feb-May;22(2-3):119–123. [PubMed] [Google Scholar]
  8. Harrer E., Harrer T., Barbosa P., Feinberg M., Johnson R. P., Buchbinder S., Walker B. D. Recognition of the highly conserved YMDD region in the human immunodeficiency virus type 1 reverse transcriptase by HLA-A2-restricted cytotoxic T lymphocytes from an asymptomatic long-term nonprogressor. J Infect Dis. 1996 Feb;173(2):476–479. doi: 10.1093/infdis/173.2.476. [DOI] [PubMed] [Google Scholar]
  9. Javaherian K., Langlois A. J., Schmidt S., Kaufmann M., Cates N., Langedijk J. P., Meloen R. H., Desrosiers R. C., Burns D. P., Bolognesi D. P. The principal neutralization determinant of simian immunodeficiency virus differs from that of human immunodeficiency virus type 1. Proc Natl Acad Sci U S A. 1992 Feb 15;89(4):1418–1422. doi: 10.1073/pnas.89.4.1418. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Klein J., Bontrop R. E., Dawkins R. L., Erlich H. A., Gyllensten U. B., Heise E. R., Jones P. P., Parham P., Wakeland E. K., Watkins D. I. Nomenclature for the major histocompatibility complexes of different species: a proposal. Immunogenetics. 1990;31(4):217–219. doi: 10.1007/BF00204890. [DOI] [PubMed] [Google Scholar]
  11. Koup R. A., Safrit J. T., Cao Y., Andrews C. A., McLeod G., Borkowsky W., Farthing C., Ho D. D. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J Virol. 1994 Jul;68(7):4650–4655. doi: 10.1128/jvi.68.7.4650-4655.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Kuwata T., Igarashi T., Ido E., Jin M., Mizuno A., Chen J., Hayami M. Construction of human immunodeficiency virus 1/simian immunodeficiency virus strain mac chimeric viruses having vpr and/or nef of different parental origins and their in vitro and in vivo replication. J Gen Virol. 1995 Sep;76(Pt 9):2181–2191. doi: 10.1099/0022-1317-76-9-2181. [DOI] [PubMed] [Google Scholar]
  13. Lawlor D. A., Warren E., Taylor P., Parham P. Gorilla class I major histocompatibility complex alleles: comparison to human and chimpanzee class I. J Exp Med. 1991 Dec 1;174(6):1491–1509. doi: 10.1084/jem.174.6.1491. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Letvin N. L. Vaccines against human immunodeficiency virus--progress and prospects. N Engl J Med. 1993 Nov 4;329(19):1400–1405. doi: 10.1056/NEJM199311043291908. [DOI] [PubMed] [Google Scholar]
  15. Li J. T., Halloran M., Lord C. I., Watson A., Ranchalis J., Fung M., Letvin N. L., Sodroski J. G. Persistent infection of macaques with simian-human immunodeficiency viruses. J Virol. 1995 Nov;69(11):7061–7067. doi: 10.1128/jvi.69.11.7061-7067.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Li J., Lord C. I., Haseltine W., Letvin N. L., Sodroski J. Infection of cynomolgus monkeys with a chimeric HIV-1/SIVmac virus that expresses the HIV-1 envelope glycoproteins. J Acquir Immune Defic Syndr. 1992;5(7):639–646. [PubMed] [Google Scholar]
  17. Machold R. P., Andrée S., Van Kaer L., Ljunggren H. G., Ploegh H. L. Peptide influences the folding and intracellular transport of free major histocompatibility complex class I heavy chains. J Exp Med. 1995 Mar 1;181(3):1111–1122. doi: 10.1084/jem.181.3.1111. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Miller M. D., Gould-Fogerite S., Shen L., Woods R. M., Koenig S., Mannino R. J., Letvin N. L. Vaccination of rhesus monkeys with synthetic peptide in a fusogenic proteoliposome elicits simian immunodeficiency virus-specific CD8+ cytotoxic T lymphocytes. J Exp Med. 1992 Dec 1;176(6):1739–1744. doi: 10.1084/jem.176.6.1739. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Miller M. D., Yamamoto H., Hughes A. L., Watkins D. I., Letvin N. L. Definition of an epitope and MHC class I molecule recognized by gag-specific cytotoxic T lymphocytes in SIVmac-infected rhesus monkeys. J Immunol. 1991 Jul 1;147(1):320–329. [PubMed] [Google Scholar]
  20. Reimann K. A., Li J. T., Voss G., Lekutis C., Tenner-Racz K., Racz P., Lin W., Montefiori D. C., Lee-Parritz D. E., Lu Y. An env gene derived from a primary human immunodeficiency virus type 1 isolate confers high in vivo replicative capacity to a chimeric simian/human immunodeficiency virus in rhesus monkeys. J Virol. 1996 May;70(5):3198–3206. doi: 10.1128/jvi.70.5.3198-3206.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Reimann K. A., Tenner-Racz K., Racz P., Montefiori D. C., Yasutomi Y., Lin W., Ransil B. J., Letvin N. L. Immunopathogenic events in acute infection of rhesus monkeys with simian immunodeficiency virus of macaques. J Virol. 1994 Apr;68(4):2362–2370. doi: 10.1128/jvi.68.4.2362-2370.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Rinaldo C., Huang X. L., Fan Z. F., Ding M., Beltz L., Logar A., Panicali D., Mazzara G., Liebmann J., Cottrill M. High levels of anti-human immunodeficiency virus type 1 (HIV-1) memory cytotoxic T-lymphocyte activity and low viral load are associated with lack of disease in HIV-1-infected long-term nonprogressors. J Virol. 1995 Sep;69(9):5838–5842. doi: 10.1128/jvi.69.9.5838-5842.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Safrit J. T., Andrews C. A., Zhu T., Ho D. D., Koup R. A. Characterization of human immunodeficiency virus type 1-specific cytotoxic T lymphocyte clones isolated during acute seroconversion: recognition of autologous virus sequences within a conserved immunodominant epitope. J Exp Med. 1994 Feb 1;179(2):463–472. doi: 10.1084/jem.179.2.463. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Shen L., Chen Z. W., Miller M. D., Stallard V., Mazzara G. P., Panicali D. L., Letvin N. L. Recombinant virus vaccine-induced SIV-specific CD8+ cytotoxic T lymphocytes. Science. 1991 Apr 19;252(5004):440–443. doi: 10.1126/science.1708168. [DOI] [PubMed] [Google Scholar]
  25. Storkus W. J., Howell D. N., Salter R. D., Dawson J. R., Cresswell P. NK susceptibility varies inversely with target cell class I HLA antigen expression. J Immunol. 1987 Mar 15;138(6):1657–1659. [PubMed] [Google Scholar]
  26. Tsubota H., Lord C. I., Watkins D. I., Morimoto C., Letvin N. L. A cytotoxic T lymphocyte inhibits acquired immunodeficiency syndrome virus replication in peripheral blood lymphocytes. J Exp Med. 1989 Apr 1;169(4):1421–1434. doi: 10.1084/jem.169.4.1421. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Voss G., Li J., Manson K., Wyand M., Sodroski J., Letvin N. L. Human immunodeficiency virus type 1 envelope glycoprotein-specific cytotoxic T lymphocytes in simian-human immunodeficiency virus-infected rhesus monkeys. Virology. 1995 Apr 20;208(2):770–775. doi: 10.1006/viro.1995.1209. [DOI] [PubMed] [Google Scholar]
  28. Voss G., Nick S., Otteken A., Lüke W., Stahl-Hennig C., Hunsmann G. Virus-specific cytotoxic T-lymphocytes in HIV-2-infected cynomolgus macaques. AIDS. 1992 Oct;6(10):1077–1083. doi: 10.1097/00002030-199210000-00003. [DOI] [PubMed] [Google Scholar]
  29. Voss G., Nick S., Stahl-Hennig C., Ritter K., Hunsmann G. Generation of macaque B lymphoblastoid cell lines with simian Epstein-Barr-like viruses: transformation procedure, characterization of the cell lines and occurrence of simian foamy virus. J Virol Methods. 1992 Sep;39(1-2):185–195. doi: 10.1016/0166-0934(92)90137-3. [DOI] [PubMed] [Google Scholar]
  30. Walker C. M., Moody D. J., Stites D. P., Levy J. A. CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication. Science. 1986 Dec 19;234(4783):1563–1566. doi: 10.1126/science.2431484. [DOI] [PubMed] [Google Scholar]
  31. Watkins D. I., Garber T. L., Chen Z. W., Toukatly G., Hughes A. L., Letvin N. L. Unusually limited nucleotide sequence variation of the expressed major histocompatibility complex class I genes of a New World primate species (Saguinus oedipus). Immunogenetics. 1991;33(2):79–89. doi: 10.1007/BF00210819. [DOI] [PubMed] [Google Scholar]
  32. Yamamoto H., Miller M. D., Watkins D. I., Snyder G. B., Chase N. E., Mazzara G. P., Gritz L., Panicali D. L., Letvin N. L. Two distinct lymphocyte populations mediate simian immunodeficiency virus envelope-specific target cell lysis. J Immunol. 1990 Dec 1;145(11):3740–3746. [PubMed] [Google Scholar]
  33. Yasutomi Y., Koenig S., Haun S. S., Stover C. K., Jackson R. K., Conard P., Conley A. J., Emini E. A., Fuerst T. R., Letvin N. L. Immunization with recombinant BCG-SIV elicits SIV-specific cytotoxic T lymphocytes in rhesus monkeys. J Immunol. 1993 Apr 1;150(7):3101–3107. [PubMed] [Google Scholar]
  34. Yasutomi Y., Palker T. J., Gardner M. B., Haynes B. F., Letvin N. L. Synthetic peptide in mineral oil adjuvant elicits simian immunodeficiency virus-specific CD8+ cytotoxic T lymphocytes in rhesus monkeys. J Immunol. 1993 Nov 1;151(9):5096–5105. [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES